Glutamine supplementation fails to affect muscle protein kinetics in critically ill patients

2002 ◽  
Vol 26 (6) ◽  
pp. 342-349 ◽  
Author(s):  
DC Gore ◽  
RR Wolfe
Author(s):  
Jonathan Cohen ◽  
Shaul Lev

Parenteral nutrition (PN) is a technique of artificial nutrition support, which consists of the intravenous administration of macronutrients, micronutrients, and water. PN has become integrated into intensive care unit (ICU) patient management with the aim of preventing energy deficits and preserving lean body mass. The addition of PN to enteral nutrition is known as supplemental PN. Parenteral feeding should be considered whenever enteral nutritional support is contraindicated, or when enteral nutrition alone is unable to meet energy and nutrient requirements. International guidelines differ considerably regarding the indications for PN. Thus, the ESPEN guidelines recommend initiating PN in critically-ill patients who do not meet caloric goals within 2–3 days of commencing EN, while the Canadian guidelines recommend PN only after extensive attempts to feed with EN have failed. The ASPEN guidelines advocate administering PN after 8 days of attempting EN unsuccessfully. Several studies have demonstrated that parenteral glutamine supplementation may improve outcome, and the ESPEN guidelines give a grade A recommendation to the use of glutamine in critically-ill patients who receive PN. Studies on IV omega-3 fatty acids have yielded promising results in animal models of acute respiratory distress syndrome and proved superior to solutions with omega -6 compositions. The discrepancy between animal models and clinical practice could be related to different time frames.


2016 ◽  
Vol 2016 ◽  
pp. 1-13 ◽  
Author(s):  
Mechteld A. R. Vermeulen ◽  
Saskia J. H. Brinkmann ◽  
Nikki Buijs ◽  
Albertus Beishuizen ◽  
Pierre M. Bet ◽  
...  

Glutamine supplementation in specific groups of critically ill patients results in favourable clinical outcome. Enhancement of citrulline and arginine synthesis by glutamine could serve as a potential mechanism. However, while receiving optimal enteral nutrition, uptake and enteral metabolism of glutamine in critically ill patients remain unknown. Therefore we investigated the effect of a therapeutically relevant dose of L-glutamine on synthesis of L-citrulline and subsequent L-arginine in this group. Ten versus ten critically ill patients receiving full enteral nutrition, or isocaloric isonitrogenous enteral nutrition including 0.5 g/kg L-alanyl-L-glutamine, were studied using stable isotopes. A cross-over design using intravenous and enteral tracers enabled splanchnic extraction (SE) calculations. Endogenous rate of appearance and SE of glutamine citrulline and arginine was not different (SE controls versus alanyl-glutamine: glutamine 48 and 48%, citrulline 33 versus 45%, and arginine 45 versus 42%). Turnover from glutamine to citrulline and arginine was not higher in glutamine-administered patients. In critically ill nonseptic patients receiving adequate nutrition and a relevant dose of glutamine there was no extra citrulline or arginine synthesis and glutamine SE was not increased. This suggests that for arginine synthesis enhancement there is no need for an additional dose of glutamine when this population is adequately fed. This trial is registered withNTR2285.


2012 ◽  
Vol 27 (4) ◽  
pp. 356-368
Author(s):  
Christina Edmunds ◽  
Jane Ziegler ◽  
Angela MacDonald

2011 ◽  
Vol 122 (3) ◽  
pp. 133-142 ◽  
Author(s):  
Maria Klaude ◽  
Maiko Mori ◽  
Inga Tjäder ◽  
Thomas Gustafsson ◽  
Jan Wernerman ◽  
...  

Muscle wasting negatively affects morbidity and mortality in critically ill patients. This progressive wasting is accompanied by, in general, a normal muscle PS (protein synthesis) rate. In the present study, we investigated whether muscle protein degradation is increased in critically ill patients with sepsis and which proteolytic enzyme systems are involved in this degradation. Eight patients and seven healthy volunteers were studied. In vivo muscle protein kinetics was measured using arteriovenous balance techniques with stable isotope tracers. The activities of the major proteolytic enzyme systems were analysed in combination with mRNA expression of genes related to these proteolytic systems. Results show that critically ill patients with sepsis have a variable but normal muscle PS rate, whereas protein degradation rates are dramatically increased (up to 160%). Of the major proteolytic enzyme systems both the proteasome and the lysosomal systems had higher activities in the patients, whereas calpain and caspase activities were not changed. Gene expression of several genes related to the proteasome system was increased in the patients. mRNA levels of the two main lysosomal enzymes (cathepsin B and L) were not changed but, conversely, genes related to calpain and caspase had a higher expression in the muscles of the patients. In conclusion, the dramatic muscle wasting seen in critically ill patients with sepsis is due to increased protein degradation. This is facilitated by increased activities of both the proteasome and lysosomal proteolytic systems.


2011 ◽  
Vol 6 (1) ◽  
pp. 28
Author(s):  
I. Luca Vasiliu ◽  
L. Mirea ◽  
R. Ungureanu ◽  
A. Balanescu ◽  
D. Pavelescu ◽  
...  

Nutrition ◽  
2020 ◽  
Vol 78 ◽  
pp. 110960
Author(s):  
Aikaterini Apostolopoulou ◽  
Anna-Bettina Haidich ◽  
Konstantinia Kofina ◽  
William Manzanares ◽  
Emmanouil Bouras ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document